{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:00:29Z","timestamp":1788537629265,"version":"build-2803163510"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T00:00:00Z","timestamp":1515974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"name":"Roche Pharmaceuticals"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.1093\/jnci\/djx288","type":"journal-article","created":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T15:21:54Z","timestamp":1513610514000},"page":"888-894","source":"Crossref","is-referenced-by-count":35,"title":["The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia"],"prefix":"10.1093","volume":"110","author":[{"given":"Michael J","family":"Overman","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Ferrarotto","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanwal","family":"Raghav","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binsah","family":"George","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, The University of Texas Medical School, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karime K","family":"Machado","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard B","family":"Saltz","sequence":"additional","affiliation":[{"name":"Memorial Sloan-Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Mazard","sequence":"additional","affiliation":[{"name":"ICM-Val d\u2019Aurelle Cancer Center, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J N","family":"Vauthey","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo M","family":"Hoff","sequence":"additional","affiliation":[{"name":"Instituto do C\u00e2ncer do Estado de S\u00e3o Paulo, Faculdade de Medicina, Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Hobbs","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn M","family":"Loyer","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Kopetz","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,1,15]]},"reference":[{"issue":"15","key":"key\n\t\t\t\t20180812195559_djx288-B1","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1200\/JCO.2009.27.5701","article-title":"Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury","volume":"28","author":"Overman","year":"2010","journal-title":"J Clin Oncol."},{"issue":"7","key":"key\n\t\t\t\t20180812195559_djx288-B2","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ejso.2007.09.007","article-title":"Effect of preoperative chemotherapy on liver resection for colorectal liver metastases","volume":"34","author":"Mehta","year":"2008","journal-title":"Eur J Surg Oncol."},{"issue":"1","key":"key\n\t\t\t\t20180812195559_djx288-B3","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0b013e31815774de","article-title":"Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy","volume":"247","author":"Nakano","year":"2008","journal-title":"Ann Surg."},{"issue":"13","key":"key\n\t\t\t\t20180812195559_djx288-B4","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J Clin Oncol."},{"issue":"4","key":"key\n\t\t\t\t20180812195559_djx288-B5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3816\/CCC.2009.n.038","article-title":"Portal hypertension associated with oxaliplatin administration: Clinical manifestations of hepatic sinusoidal injury","volume":"8","author":"Slade","year":"2009","journal-title":"Clin Colorectal Cancer."},{"issue":"31","key":"key\n\t\t\t\t20180812195559_djx288-B6","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1200\/JCO.2006.05.8156","article-title":"Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases","volume":"24","author":"Aloia","year":"2006","journal-title":"J Clin Oncol."},{"issue":"11","key":"key\n\t\t\t\t20180812195559_djx288-B7","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.ejso.2008.01.001","article-title":"Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases","volume":"34","author":"Kandutsch","year":"2008","journal-title":"Eur J Surg Oncol."},{"issue":"20","key":"key\n\t\t\t\t20180812195559_djx288-B8","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1200\/JCO.2009.21.9220","article-title":"Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer","volume":"27","author":"Allegra","year":"2009","journal-title":"J Clin Oncol."},{"issue":"5","key":"key\n\t\t\t\t20180812195559_djx288-B9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejso.2008.12.013","article-title":"Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX\/FOLFOX therapy of colorectal cancer liver metastases","volume":"35","author":"Klinger","year":"2009","journal-title":"Eur J Surg Oncol."},{"issue":"11","key":"key\n\t\t\t\t20180812195559_djx288-B10","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/hpb.12047","article-title":"Sinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: Factors predictive of severe SOS lesions and protective effect of bevacizumab","volume":"15","author":"Hubert","year":"2013","journal-title":"HPB (Oxford)."},{"issue":"12","key":"key\n\t\t\t\t20180812195559_djx288-B11","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/cncr.23099","article-title":"Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases","volume":"110","author":"Ribero","year":"2007","journal-title":"Cancer."},{"issue":"4","key":"key\n\t\t\t\t20180812195559_djx288-B12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2559.2010.03511.x","article-title":"Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis","volume":"56","author":"Rubbia-Brandt","year":"2010","journal-title":"Histopathology."},{"issue":"5","key":"key\n\t\t\t\t20180812195559_djx288-B13","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2012.07.004","article-title":"Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9","volume":"57","author":"Nakamura","year":"2012","journal-title":"J Hepatol."},{"issue":"2","key":"key\n\t\t\t\t20180812195559_djx288-B14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jss.2014.08.052","article-title":"Regorafenib suppresses sinusoidal obstruction syndrome in rats","volume":"193","author":"Okuno","year":"2015","journal-title":"J Surg Res."},{"issue":"12","key":"key\n\t\t\t\t20180812195559_djx288-B15","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.2007.14.9930","article-title":"Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: A randomized phase III study","volume":"26","author":"Saltz","year":"2008","journal-title":"J Clin Oncol."},{"issue":"suppl 2","key":"key\n\t\t\t\t20180812195559_djx288-B16","first-page":"193","article-title":"Inferring stable acquisition durations for applications of perfusion imaging in oncology","volume":"14","author":"Hobbs","year":"2015","journal-title":"Cancer Inform."},{"issue":"6","key":"key\n\t\t\t\t20180812195559_djx288-B17","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1056\/NEJM199702063360603","article-title":"Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer","volume":"336","author":"Fanucchi","year":"1997","journal-title":"N Engl J Med."},{"issue":"11","key":"key\n\t\t\t\t20180812195559_djx288-B18","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1093\/annonc\/mdm341","article-title":"Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma","volume":"18","author":"Moskowitz","year":"2007","journal-title":"Ann Oncol."},{"issue":"8","key":"key\n\t\t\t\t20180812195559_djx288-B19","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1200\/JCO.2003.09.081","article-title":"Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of Intergroup Trial C9741\/Cancer and Leukemia Group B Trial 9741","volume":"21","author":"Citron","year":"2003","journal-title":"J Clin Oncol."},{"issue":"1","key":"key\n\t\t\t\t20180812195559_djx288-B20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.6004\/jnccn.2009.0009","article-title":"Impact of chemotherapy dose intensity on cancer patient outcomes","volume":"7","author":"Lyman","year":"2009","journal-title":"J Natl Compr Canc Netw."},{"key":"key\n\t\t\t\t20180812195559_djx288-B21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12885-015-1038-y","article-title":"Adjuvant chemotherapy for stage III colon cancer: Relative dose intensity and survival among veterans","volume":"15","author":"Aspinall","year":"2015","journal-title":"BMC Cancer."},{"issue":"5","key":"key\n\t\t\t\t20180812195559_djx288-B22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1172\/JCI105380","article-title":"Pooling of platelets in the spleen: Role in the pathogenesis of \u201chypersplenic\u201d thrombocytopenia","volume":"45","author":"Aster","year":"1966","journal-title":"J Clin Invest."},{"issue":"3","key":"key\n\t\t\t\t20180812195559_djx288-B23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1537-2995.1985.25385219900.x","article-title":"Kinetics and mobilization from the spleen of indium-111-labeled platelets during platelet apheresis","volume":"25","author":"Heyns","year":"1985","journal-title":"Transfusion."},{"issue":"12","key":"key\n\t\t\t\t20180812195559_djx288-B24","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2006.09.6305","article-title":"Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200","volume":"25","author":"Giantonio","year":"2007","journal-title":"J Clin Oncol."},{"issue":"12","key":"key\n\t\t\t\t20180812195559_djx288-B25","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S1470-2045(12)70509-0","article-title":"Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): A phase 3 randomised controlled trial","volume":"13","author":"de Gramont","year":"2012","journal-title":"Lancet Oncol."},{"issue":"7","key":"key\n\t\t\t\t20180812195559_djx288-B26","doi-asserted-by":"crossref","first-page":"e21478","DOI":"10.1371\/journal.pone.0021478","article-title":"A transgenic model for conditional induction and rescue of portal hypertension reveals a role of VEGF-mediated regulation of sinusoidal fenestrations","volume":"6","author":"May","year":"2011","journal-title":"PLoS One."},{"issue":"9","key":"key\n\t\t\t\t20180812195559_djx288-B27","doi-asserted-by":"crossref","first-page":"OF1","DOI":"10.1158\/0008-5472.CAN-08-2246","article-title":"Synergistic activity of the Src family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress","volume":"69","author":"Kopetz","year":"2009","journal-title":"Cancer Res."},{"issue":"6","key":"key\n\t\t\t\t20180812195559_djx288-B28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1478-3231.2003.00880.x","article-title":"Vascular endothelial growth factor increases fenestral permeability in hepatic sinusoidal endothelial cells","volume":"23","author":"Yokomori","year":"2003","journal-title":"Liver Int."},{"issue":"4","key":"key\n\t\t\t\t20180812195559_djx288-B29","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1158\/1535-7163.MCT-10-1072","article-title":"Gene expression profiling provides insights into pathways of oxaliplatin-related sinusoidal obstruction syndrome in humans","volume":"10","author":"Rubbia-Brandt","year":"2011","journal-title":"Mol Cancer Ther."},{"issue":"2","key":"key\n\t\t\t\t20180812195559_djx288-B30","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jhep.2013.04.014","article-title":"Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model","volume":"59","author":"Robinson","year":"2013","journal-title":"J Hepatol."},{"issue":"7","key":"key\n\t\t\t\t20180812195559_djx288-B31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/jso.21276","article-title":"Hepatic regeneration is decreased in a rat model of sinusoidal obstruction syndrome","volume":"99","author":"Schiffer","year":"2009","journal-title":"J Surg Oncol."},{"issue":"4","key":"key\n\t\t\t\t20180812195559_djx288-B32","doi-asserted-by":"crossref","first-page":"G757","DOI":"10.1152\/ajpgi.00017.2004","article-title":"Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation","volume":"287","author":"DeLeve","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol."}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/110\/8\/888\/25452130\/djx288.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T02:15:11Z","timestamp":1570500911000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/110\/8\/888\/4810489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,15]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,1,15]]},"published-print":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djx288","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8]]},"published":{"date-parts":[[2018,1,15]]}}}